Yahoo! JAPAN

検索設定 - この検索結果ページについて

Fukutake Katuyuki で検索した結果 1~10件目 / 約7,950件 - 0.34秒
お知らせ:
福武 克幸ではありませんか?

ウェブ

  1. 福武 勝幸 (Katsuyuki Fukutake) - マイポータル - researchmap
    researchmap is an information sharing platform for the researchers. researchmap is provided by Japan Science and Technology Agency.
    researchmap.jp/read0064869
  2. Katsuyuki Fukutake - Researchmap
    Affiliation: Tokyo Medical University Faculty of Medicine Course of Medicine, Department of Laboratory Medicine. Degree. (BLANK)(Tokyo Medical University). J-GLOBAL ID: 200901002015112949. External link.
    researchmap.jp/read0064869/?lang=english
  3. Postmarketing safety and effectiveness of recombinant factor IX ...
    2019年6月6日 ... Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B. Katsuyuki Fukutake. Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.
    onlinelibrary.wiley.com/doi/abs/10.1111/hae.13783
  4. Safety and Efficacy of Recombinant Factor XIII (FXIII) in Patients with ...
    Katsuyuki Fukutake, MD PhD,. Katsuyuki ... Fukutake:simic: Research Funding; Sekisui Medical: Consultancy, Honoraria, Speakers Bureau; Roche Diagnostics: Honoraria, Speakers Bureau; Biogen: Consultancy, Honoraria, ...
    ashpublications.org/.../Safety-and-Efficacy-of-Recombi...
  5. Evaluation of the Safety, Efficacy of Recombinant Factor IX (nonacog ...
    Katsuyuki Fukutake, MD, PhD,. Katsuyuki Fukutake, MD, PhD *. 1Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan,. Search for other works by this author on: This Site · PubMed · Google Scholar.
    ashpublications.org/.../Evaluation-of-the-Safety-Efficac...
  6. Postmarketing safety and effectiveness of recombinant factor IX - NCBI
    2019年6月6日 ... Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B. Katsuyuki Fukutake, Masashi Taki, [...], and Toshiyuki Karumori. Additional article information ...
    www.ncbi.nlm.nih.gov/pmc/articles/PMC6852692/
  7. A multi-center post-marketing surveillance study of recombinant ...
    Akira YOSHIOKA, Akira SHIRAHATA, Katsuyuki FUKUTAKE, et al. Clinical evaluation of safety and efficacy of a plasma-derived factor VIII (CROSS EIGHT M ) in previously untreated patients with hemophilia A. Japanese Journal of Thrombosis ...
    www.jstage.jst.go.jp/article/jjsth/15/6/15_6.../en
  8. Polymorphism in RANTES chemokine promoter affects HIV-1 ...
    ... Saito, Yoshihide Ishikawa, Tatsuya Akaza, Takeo Juji, Yutaka Takebe, Takeshi Ohishi, Katsuyuki Fukutake, Yoshikazu Maruyama, Shinji Yashiki, Shunro Sonoda, Tetsuya Nakamura, Yoshiyuki Nagai, Aikichi Iwamoto, and Tatsuo Shioda.
    www.pnas.org/content/96/8/4581.short
  9. Hemophilia Treatment Center|医局紹介 | 東京医科大学 臨床検査 ...
    We have an emergency care for 24hrs everyday. Director: Dr. Katsuyuki Fukutake , Professor and Chairman Physicians: Dr. Kagehiro Amano Dr. Kazuhiko Kagawa Dr.
    team.tokyo-med.ac.jp/rinsho/info/english.html
  1  2  3  4  5  6  7  8  9  10  次へ »
検索設定 - この検索結果ページについて

Copyright (C) 2020 Yahoo Japan Corporation. All Rights Reserved.